Perfect
risk factors continued | Perfect
Company
Deck Type
Sector
Industry
Deck date
March 2022
Slide
46 of 47
Related slides by other companies
YS Biopharma
SPAC
September 2022
risk factors continued | YS Biopharma
Science 37
SPAC
October 2021
risk factors continued | Science 37
Payoneer
SPAC
May 2021
risk factors | Payoneer
Recursion Pharmaceuticals
Investor Day
January 2023
clinical no approved medical therapy standard of care colectomy during adolescence with or without removal of rectum post colectomy patients still at significant risk of polyps progressing to cancer significant decrease in quality of life post colectomy continued endoscopies and surgical intervention despite progress with surgical management the need for effective therapies for remains high due to continued risk of tumors post surgery disease overview familial adenomatous polyposis | Recursion Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights